OSCA - Olaparib Standard of CAre study - OSCA

Inclusion Criteria

• 1.First determined to have platinum-sensitive recurrent serous ovarian cancer between January 1, 2009, and December 31, 2013 (study entry period), as defined by no evidence of disease progression for at least 6 months after completion of a first-line platinum-based chemotherapy regimen; the first date of platinum-sensitive recurrence between January 1, 2009 and December 31, 2013 will define the study index date.
• 2. At least 18 years of age on the index date.
• 3. Fully documented medical history related to the patient’s ovarian cancer treatment beginning with initial diagnosis of serous ovarian cancer.
• 4. Patients can be either alive or deceased at the time of medical record abstraction.